Published in Mol Vis on November 17, 2005
Protection of visual functions by human neural progenitors in a rat model of retinal disease. PLoS One (2007) 1.38
Ex vivo gene therapy using intravitreal injection of GDNF-secreting mouse embryonic stem cells in a rat model of retinal degeneration. Mol Vis (2009) 1.03
Activated mTORC1 promotes long-term cone survival in retinitis pigmentosa mice. J Clin Invest (2015) 1.03
The use of canine models of inherited retinal degeneration to test novel therapeutic approaches. Vet Ophthalmol (2009) 0.94
Paradoxical role of BDNF: BDNF+/- retinas are protected against light damage-mediated stress. Invest Ophthalmol Vis Sci (2007) 0.82
Classical complement activation and acquired immune response pathways are not essential for retinal degeneration in the rd1 mouse. Exp Eye Res (2006) 0.82
Sustained Delivery of Bioactive GDNF from Collagen and Alginate-Based Cell-Encapsulating Gel Promoted Photoreceptor Survival in an Inherited Retinal Degeneration Model. PLoS One (2016) 0.81
Neurturin-mediated ret activation is required for retinal function. J Neurosci (2008) 0.81
Safety evaluation of poly(lactic-co-glycolic acid)/poly(lactic-acid) microspheres through intravitreal injection in rabbits. Int J Nanomedicine (2014) 0.79
NANOTECHNOLOGY IN THE TREATMENT AND DETECTION OF INTRAOCULAR CANCERS. J Biomed Nanotechnol (2008) 0.78
Efficient transduction of feline neural progenitor cells for delivery of glial cell line-derived neurotrophic factor using a feline immunodeficiency virus-based lentiviral construct. J Ophthalmol (2010) 0.77
Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina. Stem Cells Transl Med (2013) 0.77
Improvements in biomaterial matrices for neural precursor cell transplantation. Mol Cell Ther (2014) 0.77
In vitro biocompatibility of degradable biopolymers in cell line cultures from various ocular tissues: extraction studies. J Mater Sci Mater Med (2007) 0.76
The promise of stem cell-based therapeutics in ophthalmology. Neural Regen Res (2017) 0.75
Different effects of valproic acid on photoreceptor loss in Rd1 and Rd10 retinal degeneration mice. Mol Vis (2014) 0.75
Feline neural progenitor cells II: use of novel plasmid vector and hybrid promoter to drive expression of glial cell line-derived neurotrophic factor transgene. Stem Cells Int (2012) 0.75
Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa. Science (2010) 3.92
Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina (2013) 3.42
CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest (2007) 3.39
Identification and characterization of rod-derived cone viability factor. Nat Genet (2004) 2.63
Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials (2008) 2.43
Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol (2006) 2.12
Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials (2006) 1.94
Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release (2008) 1.82
Panretinal, high-resolution color photography of the mouse fundus. Invest Ophthalmol Vis Sci (2007) 1.82
Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Control Release (2006) 1.76
Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest (2012) 1.76
High resolution fundus imaging by confocal scanning laser ophthalmoscopy in the mouse. Vision Res (2005) 1.59
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors. Biomaterials (2009) 1.59
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology (2013) 1.58
Functional cone rescue by RdCVF protein in a dominant model of retinitis pigmentosa. Mol Ther (2009) 1.53
Inherited retinal degenerations: therapeutic prospects. Biol Cell (2004) 1.44
Physico-chemical stability of colloidal lipid particles. Biomaterials (2003) 1.44
Optimized allotopic expression of the human mitochondrial ND4 prevents blindness in a rat model of mitochondrial dysfunction. Am J Hum Genet (2008) 1.43
Early effects of intravitreal triamcinolone on macular edema: mechanistic implication. Ophthalmology (2006) 1.43
CCR2(+) monocytes infiltrate atrophic lesions in age-related macular disease and mediate photoreceptor degeneration in experimental subretinal inflammation in Cx3cr1 deficient mice. EMBO Mol Med (2013) 1.42
Active targeting of brain tumors using nanocarriers. Biomaterials (2007) 1.42
Interleukin-1β inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am J Pathol (2011) 1.22
A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res (2002) 1.22
Stable transmission of targeted gene modification using single-stranded oligonucleotides with flanking LNAs. Nucleic Acids Res (2005) 1.16
Role of the chemokine receptor CX3CR1 in the mobilization of phagocytic retinal microglial cells. J Neuroimmunol (2008) 1.16
Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCζ in the Goto Kakizaki rat model. Am J Pathol (2011) 1.15
The glutamate transporter EAAT5 works as a presynaptic receptor in mouse rod bipolar cells. J Physiol (2006) 1.15
Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye. Invest Ophthalmol Vis Sci (2002) 1.13
Taurine deficiency is a cause of vigabatrin-induced retinal phototoxicity. Ann Neurol (2009) 1.13
The neuroretina is a novel mineralocorticoid target: aldosterone up-regulates ion and water channels in Müller glial cells. FASEB J (2010) 1.11
Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (Lond) (2010) 1.10
CD36 deficiency leads to choroidal involution via COX2 down-regulation in rodents. PLoS Med (2008) 1.09
SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY: A Randomized Controlled Crossover Study. Retina (2015) 1.08
Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials (2009) 1.08
Vigabatrin, the GABA-transaminase inhibitor, damages cone photoreceptors in rats. Ann Neurol (2004) 1.08
In vivo anterior segment imaging in the rat eye with high speed white light full-field optical coherence tomography. Opt Express (2005) 1.07
Microglial changes occur without neural cell death in diabetic retinopathy. Vision Res (2006) 1.06
The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials (2010) 1.05
Placental growth factor contributes to micro-vascular abnormalization and blood-retinal barrier breakdown in diabetic retinopathy. PLoS One (2011) 1.04
Excessive activation of cyclic nucleotide-gated channels contributes to neuronal degeneration of photoreceptors. Eur J Neurosci (2005) 1.04
Perfusional deficit and the dynamics of cerebral edemas in experimental traumatic brain injury using perfusion and diffusion-weighted magnetic resonance imaging. J Neurotrauma (2007) 1.04
Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes. Invest Ophthalmol Vis Sci (2007) 1.03
Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? Int J Pharm (2011) 1.03
Glucocorticoids induce retinal toxicity through mechanisms mainly associated with paraptosis. Mol Vis (2007) 1.02
Retinal-cell-conditioned medium prevents TNF-alpha-induced apoptosis of purified ganglion cells. Invest Ophthalmol Vis Sci (2005) 1.02
The importance of the stem cell marker prominin-1/CD133 in the uptake of transferrin and in iron metabolism in human colon cancer Caco-2 cells. PLoS One (2011) 1.02
The outer limiting membrane (OLM) revisited: clinical implications. Clin Ophthalmol (2010) 1.02
Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials (2010) 1.01
Evidence for glutamate-mediated excitotoxic mechanisms during photoreceptor degeneration in the rd1 mouse retina. Mol Vis (2005) 1.01
Treatment of epilepsy: the GABA-transaminase inhibitor, vigabatrin, induces neuronal plasticity in the mouse retina. Eur J Neurosci (2008) 1.01
Voltage-gated channels and calcium homeostasis in mammalian rod photoreceptors. J Neurophysiol (2004) 1.00
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments. Biomaterials (2007) 1.00
Passive and active tumour targeting with nanocarriers. Curr Drug Discov Technol (2011) 1.00
A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm Res (2002) 0.99
Poly-epsilon-caprolactone intravitreous devices: an in vivo study. Invest Ophthalmol Vis Sci (2008) 0.99
Nano-emulsions and nanocapsules by the PIT method: an investigation on the role of the temperature cycling on the emulsion phase inversion. Int J Pharm (2007) 0.98
Ocular gene therapy: a review of nonviral strategies. Mol Vis (2006) 0.98
A low-cost and simple imaging technique of the anterior and posterior segments: eye fundus, ciliary bodies, iridocorneal angle. Invest Ophthalmol Vis Sci (2008) 0.98
Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye. Invest Ophthalmol Vis Sci (2008) 0.97
A review of the current status of siRNA nanomedicines in the treatment of cancer. Biomaterials (2013) 0.95
Single-stranded oligonucleotide-mediated in vivo gene repair in the rd1 retina. Mol Vis (2007) 0.95
Distribution of vesicular glutamate transporters in rat and human retina. Brain Res (2006) 0.95
In vivo observation of the locomotion of microglial cells in the retina. Glia (2010) 0.94
Lack of Niemann-Pick type C1 induces age-related degeneration in the mouse retina. Mol Cell Neurosci (2009) 0.94
Recurrence of keratoconus characteristics: a clinical and histologic follow-up analysis of donor grafts. Ophthalmology (2003) 0.94
Taurine deficiency damages photoreceptors and retinal ganglion cells in vigabatrin-treated neonatal rats. Mol Cell Neurosci (2010) 0.94
Downregulation of IRS-1 expression causes inhibition of corneal angiogenesis. Invest Ophthalmol Vis Sci (2005) 0.93
The potential of combinations of drug-loaded nanoparticle systems and adult stem cells for glioma therapy. Biomaterials (2010) 0.92
Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel. Eur J Pharm Biopharm (2009) 0.92
Purified neurons can survive on peptide-free graphene layers. Adv Healthc Mater (2013) 0.91
Lontophoresis for the treatment of paecilomyces keratitis. Cornea (2002) 0.90
In vivo gene transfer into the ocular ciliary muscle mediated by ultrasound and microbubbles. Ultrasound Med Biol (2011) 0.90
Influence of size, surface coating and fine chemical composition on the in vitro reactivity and in vivo biodistribution of lipid nanocapsules versus lipid nanoemulsions in cancer models. Nanomedicine (2012) 0.90
Brain targeting using novel lipid nanovectors. J Control Release (2007) 0.90
Anti-cancer drug diffusion within living rat brain tissue: an experimental study using [3H](6)-5-fluorouracil-loaded PLGA microspheres. Eur J Pharm Biopharm (2002) 0.90
Controlled delivery of 5-chlorouracil using poly(ortho esters) in filtering surgery for glaucoma. Invest Ophthalmol Vis Sci (2008) 0.90
Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials (2010) 0.90
Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm (2008) 0.90
Late histological and functional changes in the P23H rat retina after photoreceptor loss. Neurobiol Dis (2010) 0.90
A peptide inhibitor of c-Jun N-terminal kinase for the treatment of endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (2010) 0.90
The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability. Biomaterials (2010) 0.90